Allied Market Research

2024

Respiratory Infectious Disease Diagnostics Market

Respiratory Infectious Disease Diagnostics Market Size, Share, Competitive Landscape and Trend Analysis Report by Test Type, by Disease Type and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

According to the World Health Organization (WHO), respiratory infectious diseases are the third leading cause of death and result in over all three million deaths per year across the world. These diseases include pneumonia, bronchitis, sinus infections, laryngitis, and others. During the diagnostics of respiratory diseases, doctor mainly focuses on breathing issues and X-ray or CT scan to check the lower respiratory tract. Sometimes, fluid and inflammation in the lungs is also checked.

Rise in prevalence of respiratory diseases, growth in adoption of advanced molecular techniques, increase in geriatric population, and initiatives taken by government and non-profile organization to minimize the incidence of infectious diseases drive the market. However, factors such as lack of awareness about diagnostic solution and high cost of laboratory testing restrain the market growth. Further, development of cost effective tools for the infectious disease diagnosis and growth in concern about the disease in low-income countries provide lucrative opportunities for the market growth during the forecast period.

The respiratory infectious disease diagnostics market is segmented based on test type, disease type, end user, and region. Based on test type, it is categorized into mechanical tests, imaging tests, and in vitro diagnostics (IVD) tests. Mechanical tests are further segmented into spirometry, peak flow test, blood gas test, pulmonary function test, and obstructive sleep apnea (OSA) diagnostic test. In vitro diagnostics (IVD) tests are further divided into point-of-care (POC) test, molecular diagnostic test, and other tests. On the basis of disease type, the market is classified into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. On the basis of end user, the market is divided into hospital, clinical laboratories, physician offices, and other end users. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include Abbott Laboratories, Thermo Fisher Scientific Inc., Alere, Inc., Koninklijke Philips N.V., Cardinal Health, COSMED, Smiths Group plc, NIHON KOHDEN CORPORATION, Becton, Dickinson and Company, and F. Hoffmann-La Roche AG.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global respiratory infectious disease diagnostics market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market¬†which helps to determine the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the global respiratory infectious disease diagnostics market.

Respiratory Infectious Disease Diagnostics Market Report Highlights

Aspects Details
icon_5
By Test Type
  • Mechanical tests
  • Imaging Tests
  • In Vitro Diagnostics (IVD) Tests
icon_6
By Disease Type
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Tuberculosis
  • Other Diseases
icon_7
By End User
  • Hospitals
  • Physician Offices
  • Clinical Laboratories
  • Other End Users
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_9
Key Market Players

COSMED, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., NIHON KOHDEN CORPORATION,, F. Hoffmann-La Roche AG., Alere, Inc., Becton, Dickinson and Company, Cardinal Health, Abbott Laboratories, Smiths Group plc

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Respiratory Infectious Disease Diagnostics Market

Global Opportunity Analysis and Industry Forecast, 2023-2032